Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Qin Li
Based on 21 articles published since 2010
(Why 21 articles?)
||||
Expertise Level
The expertise of Qin Li ranks in the
  • Top 2%
  • ... of 89,464 published authors worldwide on Parkinson Disease
  • ... from 2010 through 2020
  • ... based on contributions to 21 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    Miscellaneous institutions in Beijing      
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
  • Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Department of Philosophy, Human, Social and Educational Sciences, University of Perugia, 06100 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Clinica Neurologica, Università degli studi di Perugia, Ospedale Santa Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Experimental Neurophysiology Laboratory, IRCCS San Raffaele Pisana, University San Raffaele, Rome, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. Electronic address: · Pubmed 30261285
2018
  • Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain. · Servicio de Neurología, Complejo Hospitalario de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Clínica Universidad de Navarra, Servicio de Neurología, Avenida Pío XII, 31008 Pamplona, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. Electronic address: · Pubmed 29936234
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, Section of Toxicology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28739086
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 28539659
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2016
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
  • University de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Laboratory Animal Sciences, Beijing, China. · Laboratory of Neurophysiology and Plasticity, Fondazione Santa Lucia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy. · University de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. Electronic address: · Pubmed 25146322
2015
  • Univ. de Bordeaux, UMR 5293, F-33000 Bordeaux, France CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing 100101, China. · Univ. de Bordeaux, UMR 5293, F-33000 Bordeaux, France CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing 100101, China. · Pubmed 24770706
2014
  • Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24572591
  • 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · 1] Motac neuroscience, Manchester, UK [2] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Life Sciences and Biotechnology (SVeB), University of Ferrara, Ferrara, Italy. · Institute of Pharmacology and Toxicology, Charité Campus Mitte, Humboldt University, 10117 Berlin, Germany. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK [4] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China [5] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France [4] Centre de référence AMS, CHU de Bordeaux, 33076 Bordeaux, France. · Pubmed 24429495
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Pharmaceutical Biosciences, Biomolecular Imaging and Proteomics, Uppsala University, Box 591, SE-75124 Uppsala, Sweden. · Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24148855
Probable:    Miscellaneous institutions in Manchester, UK      
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
  • Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Department of Philosophy, Human, Social and Educational Sciences, University of Perugia, 06100 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Clinica Neurologica, Università degli studi di Perugia, Ospedale Santa Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Experimental Neurophysiology Laboratory, IRCCS San Raffaele Pisana, University San Raffaele, Rome, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. Electronic address: · Pubmed 30261285
2018
  • Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain. · Servicio de Neurología, Complejo Hospitalario de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Clínica Universidad de Navarra, Servicio de Neurología, Avenida Pío XII, 31008 Pamplona, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. Electronic address: · Pubmed 29936234
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, Section of Toxicology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28739086
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 28539659
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2016
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom. · Motac Neuroscience Ltd, Manchester, United Kingdom; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 27424102
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 21 total) written by Qin Li about Parkinson Disease:

  • Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease. 2019
  • NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology. 2019
  • The expression of cannabinoid type 1 receptor and 2-arachidonoyl glycerol synthesizing/degrading enzymes is altered in basal ganglia during the active phase of levodopa-induced dyskinesia. 2018
  • Decreased Rhes mRNA levels in the brain of patients with Parkinson's disease and MPTP-treated macaques. 2017
  • A preclinical study on the combined effects of repeated eltoprazine and preladenant treatment for alleviating L-DOPA-induced dyskinesia in Parkinson's disease. 2017
  • Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia. 2017
  • Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primate. 2017
  • An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models. 2016
  • Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. 2016
  • Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease. 2016
Show List of Full Article Records
Google Searches

Learn more about Qin Li using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in Beijing
Miscellaneous institutions in Manchester, UK
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in Beijing
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
  • Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Department of Philosophy, Human, Social and Educational Sciences, University of Perugia, 06100 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Clinica Neurologica, Università degli studi di Perugia, Ospedale Santa Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Experimental Neurophysiology Laboratory, IRCCS San Raffaele Pisana, University San Raffaele, Rome, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. Electronic address: · Pubmed 30261285
2018
  • Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain. · Servicio de Neurología, Complejo Hospitalario de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Clínica Universidad de Navarra, Servicio de Neurología, Avenida Pío XII, 31008 Pamplona, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. Electronic address: · Pubmed 29936234
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, Section of Toxicology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28739086
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 28539659
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2016
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
  • University de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. · China Academy of Medical Sciences, Institute of Laboratory Animal Sciences, Beijing, China. · Laboratory of Neurophysiology and Plasticity, Fondazione Santa Lucia, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy. · University de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France; National Centre for Scientific Research, Institut des Maladies Neurodégénératives, Bordeaux, France. Electronic address: · Pubmed 25146322
2015
  • Univ. de Bordeaux, UMR 5293, F-33000 Bordeaux, France CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing 100101, China. · Univ. de Bordeaux, UMR 5293, F-33000 Bordeaux, France CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing 100101, China. · Pubmed 24770706
2014
  • Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience Ltd., Manchester, United Kingdom; Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux F-33000, France; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24572591
  • 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France. · 1] Motac neuroscience, Manchester, UK [2] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Life Sciences and Biotechnology (SVeB), University of Ferrara, Ferrara, Italy. · Institute of Pharmacology and Toxicology, Charité Campus Mitte, Humboldt University, 10117 Berlin, Germany. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Motac neuroscience, Manchester, UK [4] Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China [5] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France. · Department of Medical Sciences, Section of Pharmacology, University of Ferrara, Ferrara, Italy. · 1] Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [2] CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000 Bordeaux, France [3] Service de Neurologie, Centre Expert Parkinson, CHU de Bordeaux, 33076 Bordeaux, France [4] Centre de référence AMS, CHU de Bordeaux, 33076 Bordeaux, France. · Pubmed 24429495
  • Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France. · Department of Pharmaceutical Biosciences, Biomolecular Imaging and Proteomics, Uppsala University, Box 591, SE-75124 Uppsala, Sweden. · Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France; Motac Neuroscience, Manchester, UK; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. Electronic address: · Pubmed 24148855
Miscellaneous institutions in Manchester, UK
2019
  • Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Motac Neuroscience, Manchester, UK. · CIC Toulouse, Toulouse, France. · Départements de Pharmacologie Clinique et Neurosciences, INSERM CIC9302, CHU de Toulouse, Toulouse, France. · Service de Pharmacologie, Faculté de Médecine, CHU de Toulouse, Université de Toulouse, Toulouse, France. · Service de Neurologie, Hôpital Pellegrin, CHU de Bordeaux, 33000, Bordeaux, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, 146 rue Léo Saignat, 33000, Bordeaux Cedex, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Department Medicine, University of Otago, Christchurch, New Zealand. · New Zealand Brain Research Institute, Christchurch, New Zealand. · Pubmed 31098725
  • Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Department of Philosophy, Human, Social and Educational Sciences, University of Perugia, 06100 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Laboratory of Neurophysiology, Santa Lucia Foundation, IRCCS, 00100 Rome, Italy; Clinica Neurologica, Università degli studi di Perugia, Ospedale Santa Maria della Misericordia, S. Andrea delle Fratte, 06156 Perugia, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Experimental Neurophysiology Laboratory, IRCCS San Raffaele Pisana, University San Raffaele, Rome, Italy. · Dipartimento di Scienze Farmacologiche e Biomolecolari (DiSFeB), Università degli Studi di Milano - La Statale, 20133 Milano, Italy. Electronic address: · Pubmed 30261285
2018
  • Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain. · Servicio de Neurología, Complejo Hospitalario de Navarra, Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain; Clínica Universidad de Navarra, Servicio de Neurología, Avenida Pío XII, 31008 Pamplona, Spain. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Universidad de Navarra, Facultad de Ciencias, Departamento de Bioquímica y Genética, Avenida Pío XII, 31008 Pamplona, Spain; Universidad de Navarra, CIMA, Programa de Neurociencias, Avenida Pío XII, 31008 Pamplona, Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Spain. Electronic address: · Pubmed 29936234
2017
  • Ceinge Biotecnologie Avanzate, Naples, Italy. · Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy. · Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America. · Department of Biology Unit of Cell and Developmental Biology, University of Pisa, Pisa, Italy. · Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania, Luigi Vanvitelli, Italy. · Motac Neuroscience, UK-M15 6WE, Manchester, United Kingdom. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Université de Bordeaux, Institut des Maladies Neurodégénératives,Bordeaux, France. · Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France. · IRCSS Casa Sollievo della Sofferenza, ISBReMIT-Institute for Stem Cell Biology, Regenerative Medicine and Innovative Therapies, San Giovanni Rotondo, Italy. · Department of Medicine, University of Perugia and Clinica Neurologica, Santa Maria della Misericordia Hospital, Perugia, Italy. · National Research Council of Italy (CNR), Neuroscience Institute, Cagliari, Italy. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Center for Neuroscience and Cognitive Systems, Istituto Italiano di Tecnologia, Rovereto, TN, Italy. · Neuroscience Institute, National Research Council (CNR), Pisa, Italy. · Pubmed 28742811
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, Section of Toxicology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Department of Biomedical Sciences, Section of Physiology, University of Cagliari, University Campus, SS554 km 4.5, 09042 Monserrato, Italy. · Motac Neuroscience Ltd, Manchester, United Kingdom; Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 28739086
  • Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Canada. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000, Bordeaux, France. · Motac neuroscience Ltd, Manchester, UK. · Institute of Lab Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Pubmed 28539659
  • Department of Clinical Neurosciences, Institute of Neurology, University College London, NW3 2PF, United Kingdom. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing City, People's Republic of China. · University de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, F-33000, France. · Pubmed 28295625
2016
  • Motac Neuroscience Ltd, Manchester, United Kingdom. Electronic address: · Motac Neuroscience Ltd, Manchester, United Kingdom. · Motac Neuroscience Ltd, Manchester, United Kingdom; Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, F-33000 Bordeaux, France. · Pubmed 27424102
  • National Research Council of Italy, Neuroscience Institute, Cagliari, Italy. · Motac Neuroscience Ltd, Manchester, UK. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, China. · Department of Biomedical Sciences, section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy. · Department of Biomedical Sciences, section of Physiology, University of Cagliari, Cagliari, Italy. · Department of Chemical and Pharmaceutical Sciences, University of Ferrara, Ferrara, Italy. · Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, Bordeaux, France. · Pubmed 26871939
  • Cynbiose, Marcy l'Etoile, France. · Univ. de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · CNRS, Institut des Maladies Neurodégénératives, UMR 5293, 33000, Bordeaux, France. · Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, People's Republic of China, 100050. · Motac Neuroscience, Manchester, United Kingdom. · Institute of Laboratory Animal Sciences, China Academy of Medical Sciences, Beijing, People's Republic of China. · Pubmed 26799359
5 Other Locations Show
Yearly article counts 02144133201
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.